BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790 | -17.2% | 20,934 | 0.0% | 0.78% | -5.8% |
| Q2 2023 | $954 | +374.6% | 20,934 | +432.1% | 0.83% | +292.0% |
| Q4 2022 | $201 | -99.9% | 3,934 | 0.0% | 0.21% | -10.5% |
| Q3 2022 | $212,000 | -17.5% | 3,934 | -1.9% | 0.24% | -10.9% |
| Q2 2022 | $257,000 | -17.4% | 4,009 | 0.0% | 0.27% | +4.3% |
| Q1 2022 | $311,000 | -9.6% | 4,009 | 0.0% | 0.26% | +9.9% |
| Q4 2021 | $344,000 | -2.0% | 4,009 | -8.2% | 0.23% | +6.9% |
| Q3 2021 | $351,000 | -0.3% | 4,367 | 0.0% | 0.22% | +8.5% |
| Q2 2021 | $352,000 | -4.3% | 4,367 | 0.0% | 0.20% | -6.1% |
| Q1 2021 | $368,000 | +5.1% | 4,367 | 0.0% | 0.21% | -7.0% |
| Q4 2020 | $350,000 | -0.3% | 4,367 | 0.0% | 0.23% | -28.9% |
| Q3 2020 | $351,000 | -1.1% | 4,367 | 0.0% | 0.32% | -24.9% |
| Q1 2020 | $355,000 | -3.5% | 4,367 | -0.8% | 0.43% | +30.0% |
| Q4 2019 | $368,000 | -34.3% | 4,400 | -31.2% | 0.33% | -31.7% |
| Q3 2019 | $560,000 | +6.9% | 6,400 | 0.0% | 0.48% | +31.6% |
| Q2 2019 | $524,000 | +0.8% | 6,400 | 0.0% | 0.37% | +7.3% |
| Q1 2019 | $520,000 | -6.0% | 6,400 | -23.8% | 0.34% | -20.3% |
| Q4 2018 | $553,000 | -14.7% | 8,400 | 0.0% | 0.43% | +10.3% |
| Q3 2018 | $648,000 | +4.5% | 8,400 | 0.0% | 0.39% | -12.4% |
| Q2 2018 | $620,000 | +171.9% | 8,400 | +140.0% | 0.44% | +116.6% |
| Q1 2018 | $228,000 | +0.9% | 3,500 | 0.0% | 0.20% | -5.5% |
| Q4 2017 | $226,000 | +2.7% | 3,500 | 0.0% | 0.22% | -5.7% |
| Q3 2017 | $220,000 | +3.8% | 3,500 | 0.0% | 0.23% | -2.1% |
| Q2 2017 | $212,000 | +5.0% | 3,500 | -10.3% | 0.24% | +13.0% |
| Q1 2017 | $202,000 | -52.7% | 3,900 | -37.5% | 0.21% | -41.9% |
| Q1 2015 | $427,000 | -75.4% | 6,240 | -73.7% | 0.36% | -76.0% |
| Q4 2014 | $1,739,000 | +4.8% | 23,723 | +2.6% | 1.49% | +6.3% |
| Q3 2014 | $1,660,000 | +0.2% | 23,123 | +0.9% | 1.40% | +20.3% |
| Q2 2014 | $1,657,000 | -2.1% | 22,923 | -0.3% | 1.17% | -1.8% |
| Q1 2014 | $1,692,000 | +6.5% | 22,990 | +0.7% | 1.19% | +10.7% |
| Q4 2013 | $1,589,000 | +5.9% | 22,840 | 0.0% | 1.07% | -0.6% |
| Q3 2013 | $1,500,000 | -5.2% | 22,840 | 0.0% | 1.08% | -14.2% |
| Q2 2013 | $1,582,000 | – | 22,840 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |